Bioventus Inc.

BVS - CIK 0001665988

Market cap-

Rank-

SEC filings445

BVS balance sheet (annual)

The table below shows Bioventus Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Cash & equivalents	$51.24M	$41.58M	$36.96M	$31.81M	$43.93M
Short-term investments	-	-	-	-	-
Receivables	$128.30M	$127.39M	$122.79M	$136.65M	$124.96M
Inventory	$82.24M	$92.47M	$91.33M	$85.41M	$61.69M
Total current assets	$272.84M	$275.61M	$268.00M	$272.57M	$263.10M

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.